G. Esposito, A. Rapacciuolo, N. Prasad, S. Takaoka, H. Thomas et al., Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress, Circulation, vol.105, issue.1, pp.85-92, 2002.
DOI : 10.1161/hc0102.101365

J. Hill, M. Karimi, W. Kutschke, R. Davisson, K. Zimmerman et al., Cardiac Hypertrophy Is Not a Required Compensatory Response to Short-Term Pressure Overload, Circulation, vol.101, issue.24, pp.2863-2869, 2000.
DOI : 10.1161/01.CIR.101.24.2863

N. Frey and E. Olson, Cardiac Hypertrophy: The Good, the Bad, and the Ugly, Annual Review of Physiology, vol.65, issue.1, pp.45-79, 2003.
DOI : 10.1146/annurev.physiol.65.092101.142243

J. Heineke and J. Molkentin, Regulation of cardiac hypertrophy by intracellular signalling pathways, Nature Reviews Molecular Cell Biology, vol.124, issue.8, pp.589-600, 2006.
DOI : 10.1038/nrm1983

J. Molkentin and D. Gwn, Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy, Annual Review of Physiology, vol.63, issue.1, pp.391-426, 2001.
DOI : 10.1146/annurev.physiol.63.1.391

M. Lohse, S. Engelhardt, and T. Eschenhagen, What Is the Role of ??-Adrenergic Signaling in Heart Failure?, Circulation Research, vol.93, issue.10, pp.896-906, 2003.
DOI : 10.1161/01.RES.0000102042.83024.CA

N. Salazar, J. Chen, and H. Rockman, Cardiac GPCRs: GPCR signaling in healthy and failing hearts, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1768, issue.4, pp.1006-1018, 2007.
DOI : 10.1016/j.bbamem.2007.02.010

M. Kelm, S. Schafer, S. Mingers, M. Heydthausen, M. Vogt et al., Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients, Journal of Hypertension, vol.14, issue.11, pp.1357-1364, 1996.
DOI : 10.1097/00004872-199611000-00015

K. Zen, H. Irie, T. Doue, M. Takamiya, T. Yamano et al., Analysis of Circulating Apoptosis Mediators and Proinflammatory Cytokines in Patients With Idiopathic Hypertrophic Cardiomyopathy, International Heart Journal, vol.46, issue.2, pp.231-244, 2005.
DOI : 10.1536/ihj.46.231

G. Li, R. Li, D. Mickle, R. Weisel, F. Merante et al., Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism, Circulation, vol.98, pp.144-149, 1998.

H. Ushikoshi, T. Takahashi, X. Chen, N. Khai, M. Esaki et al., Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes, Laboratory Investigation, vol.310, issue.7, pp.862-873, 2005.
DOI : 10.1038/labinvest.3700282

A. Burger, M. Benicke, A. Deten, and H. Zimmer, Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts, Am J Physiol Heart Circ Physiol, vol.281, pp.14-21, 2001.

F. Jaffré, J. Callebert, A. Sarre, N. Etienne, C. Nebigil et al., Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1??, and Tumor Necrosis Factor-?? Cytokine Production by Ventricular Fibroblasts, Circulation, vol.110, issue.8, pp.969-974, 2004.
DOI : 10.1161/01.CIR.0000139856.20505.57

M. Sano, K. Fukuda, H. Kodama, J. Pan, M. Saito et al., Interleukin-6 Family of Cytokines Mediate Angiotensin II-induced Cardiac Hypertrophy in Rodent Cardiomyocytes, Journal of Biological Chemistry, vol.275, issue.38, pp.29717-29723, 2000.
DOI : 10.1074/jbc.M003128200

H. Hirota, K. Yoshida, T. Kishimoto, and T. Taga, Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice., Proceedings of the National Academy of Sciences, vol.92, issue.11, pp.4862-4866, 1995.
DOI : 10.1073/pnas.92.11.4862

N. Sivasubramanian, M. Coker, K. Kurrelmeyer, W. Maclellan, F. Demayo et al., Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor, Circulation, vol.104, issue.7, pp.826-831, 2001.
DOI : 10.1161/hc3401.093154

K. Nishikawa, M. Yoshida, M. Kusuhara, N. Ishigami, K. Isoda et al., Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1, AJP: Heart and Circulatory Physiology, vol.291, issue.1, pp.176-183, 2006.
DOI : 10.1152/ajpheart.00269.2005

C. Long, W. Hartogensis, and P. Simpson, ??-Adrenergic Stimulation of Cardiac Non-myocytes Augments the Growth-promoting Activity of Non-myocyte Conditioned Medium, Journal of Molecular and Cellular Cardiology, vol.25, issue.8, pp.915-925, 1993.
DOI : 10.1006/jmcc.1993.1104

M. Schafer, K. Frischkopf, G. Taimor, H. Piper, and K. Schluter, Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat, Am J Physiol Cell Physiol, vol.279, pp.495-503, 2000.

K. Schluter and H. Piper, Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes, Am J Physiol, vol.263, pp.1739-1746, 1992.

C. Nebigil, N. Etienne, N. Messaddeq, and L. Maroteaux, Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B-receptor signaling, The FASEB Journal, vol.17, pp.1373-1375, 2003.
DOI : 10.1096/fj.02-1122fje

C. Nebigil, F. Jaffré, N. Messaddeq, P. Hickel, L. Monassier et al., Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy, Circulation, vol.107, issue.25, pp.3223-3229, 2003.
DOI : 10.1161/01.CIR.0000074224.57016.01

C. Nebigil, P. Hickel, N. Messaddeq, J. Vonesch, M. Douchet et al., Ablation of Serotonin 5-HT2B Receptors in Mice Leads to Abnormal Cardiac Structure and Function, Circulation, vol.103, issue.24, pp.2973-2979, 2001.
DOI : 10.1161/01.CIR.103.24.2973

L. Monassier, M. Laplante, F. Jaffre, P. Bousquet, L. Maroteaux et al., Serotonin 5-HT2B Receptor Blockade Prevents Reactive Oxygen Species-Induced Cardiac Hypertrophy in Mice, Hypertension, vol.52, issue.2, pp.301-307, 2008.
DOI : 10.1161/HYPERTENSIONAHA.107.105551

URL : https://hal.archives-ouvertes.fr/inserm-00484531

C. Nebigil, D. Choi, A. Dierich, P. Hickel, L. Meur et al., Serotonin 2B receptor is required for heart development, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.9508-9513, 2000.
DOI : 10.1073/pnas.97.17.9508

L. Landeen, N. Aroonsakool, J. Haga, B. Hu, and W. Giles, Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions, AJP: Heart and Circulatory Physiology, vol.292, issue.6, pp.2698-2711, 2007.
DOI : 10.1152/ajpheart.01065.2006

K. Tanimoto, F. Sugiyama, Y. Goto, J. Ishida, E. Takimoto et al., Angiotensinogen-deficient mice with hypotension, J Biol Chem, vol.269, pp.31334-31337, 1994.

N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham et al., EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF, Nature, vol.402, pp.884-888, 1999.

K. Pierce, L. Luttrell, and R. Lefkowitz, New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades, Oncogene, vol.20, issue.13, pp.1532-1539, 2001.
DOI : 10.1038/sj.onc.1204184

M. Bader, Role of the Local Renin???angiotensin System in Cardiac Damage: a Minireview Focussing on Transgenic Animal Models, Journal of Molecular and Cellular Cardiology, vol.34, issue.11, pp.1455-1462, 2002.
DOI : 10.1006/jmcc.2002.2077

D. Dostal, G. Booz, and K. Baker, Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and ??-adrenergic stimulation, Basic Research in Cardiology, vol.95, issue.6, pp.485-490, 2000.
DOI : 10.1007/s003950070025

H. Ohtsu, P. Dempsey, G. Frank, E. Brailoiu, S. Higuchi et al., ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II, Arterioscler Thromb Vasc Biol, vol.26, pp.133-137, 2006.

M. Gooz, P. Gooz, L. Luttrell, and J. Raymond, 5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-??-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells, Journal of Biological Chemistry, vol.281, issue.30, pp.21004-21012, 2006.
DOI : 10.1074/jbc.M512096200

C. Hinkle, S. Sunnarborg, D. Loiselle, C. Parker, M. Stevenson et al., Selective Roles for Tumor Necrosis Factor ??-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family: THE JUXTAMEMBRANE STALK DETERMINES CLEAVAGE EFFICIENCY, Journal of Biological Chemistry, vol.279, issue.23, pp.24179-24188, 2004.
DOI : 10.1074/jbc.M312141200

M. Pietri, B. Schneider, S. Mouillet-richard, M. Ermonval, V. Mutel et al., Reactive oxygen species-dependent TNF-?? converting enzyme activation through stimulation of 5-HT2B and ??1D autoreceptors in neuronal cells, The FASEB Journal, vol.19, issue.9, pp.1078-1087, 2005.
DOI : 10.1096/fj.04-3631com

S. Bulenger, S. Marullo, and M. Bouvier, Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation, Trends in Pharmacological Sciences, vol.26, issue.3, pp.131-137, 2005.
DOI : 10.1016/j.tips.2005.01.004

S. Gavarini, C. Becamel, B. Chanrion, J. Bockaert, and P. Marin, Molecular and Functional Characterization of Proteins Interacting with the C-Terminal Domains of 5-HT2 Receptors: Emergence of 5-HT2 ???Receptosomes???, Biology of the Cell, vol.96, issue.5, pp.373-381, 2004.
DOI : 10.1111/j.1768-322X.2004.tb01429.x

L. Barki-harrington, L. Luttrell, and H. Rockman, Dual Inhibition of ??-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for Receptor-Receptor Interaction In Vivo, Circulation, vol.108, issue.13, pp.1611-1618, 2003.
DOI : 10.1161/01.CIR.0000092166.30360.78

T. Thum, P. Galuppo, C. Wolf, J. Fiedler, S. Kneitz et al., WITHDRAWN: MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure, Journal of Molecular and Cellular Cardiology, vol.116, pp.258-267, 2007.
DOI : 10.1016/j.yjmcc.2007.03.815

T. Koyanagi, L. Wong, K. Inagaki, O. Petrauskene, and D. Mochly-rosen, Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats, AJP: Heart and Circulatory Physiology, vol.295, issue.1, pp.222-226, 2008.
DOI : 10.1152/ajpheart.00289.2008

J. Hall, E. Birks, S. Grindle, M. Cullen, P. Barton et al., Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy, European Heart Journal, vol.28, issue.5, pp.613-627, 2007.
DOI : 10.1093/eurheartj/ehl365

T. Brattelid, E. Qvigstad, J. Birkeland, F. Swift, S. Bekkevold et al., Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle, Journal of Molecular and Cellular Cardiology, vol.43, issue.6, pp.767-779, 2007.
DOI : 10.1016/j.yjmcc.2007.08.019

Y. Liang, L. Lai, B. Wang, S. Juang, C. Chang et al., Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-??B in cardiomyocytes, Cardiovascular Research, vol.72, issue.2, pp.303-312, 2006.
DOI : 10.1016/j.cardiores.2006.08.003